Five-Year Registration Validity and Renewal in Nigeria under Article 4(7)
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The validity period of a medical device registration certificate in Nigeria is 5 years, and it can be renewed. This figure is consistent in three places across the Regulations and the two registration guidelines: Article 4(7) of the Regulations, §11.2 of VBM-R&RA-GDL-001-01, and §12.2 of R&R-GDL-008-02.
What is genuinely easy to overlook is Article 8(3): where a device registration has been suspended or cancelled on any of the grounds listed in Article 8(1), a holder who wishes to resume placing the device on the market (resumption) must notify NAFDAC and, where the certificate has already expired, pay the renewal fee. In other words, resumption after suspension is neither automatic nor free of charge. The two actions are cumulative: the notice tells NAFDAC that the holder intends to return to the market, while the fee covers the administrative restoration of a lapsed certificate. Companies that treat suspension as a temporary, self-curing event routinely discover at the worst possible moment that their certificate is no longer valid and that reinstatement involves an application, a fee, and renewed scrutiny of their dossier.
2. Legal basis
| Regulation | Reference number | Publication date | Provisions |
|---|---|---|---|
| NAFDAC Medical Devices and Related Products (Registration, Labelling and Advertisement) Regulations, 2024 | S.I. No. 42 of 2024 | 16 October 2024 | Article 4(7) (5-year validity, renewable), Articles 8(1)–(3) (suspension, cancellation and resumption), Article 4(1)(c) (evidence of fee payment) |
| NAFDAC Guidelines for Registration of Medical Devices Including In Vitro Diagnostics (IVDs) and Related Products | VBM-R&RA-GDL-001-01 | Effective 10 April 2025 | §11.2 (5-year validity), §11.5 (payment does not equal registration status), §10.0 (fees) |
| NAFDAC Guidelines for Registration of Medical Devices (Imported and Locally Manufactured) in Nigeria | R&R-GDL-008-02 | Effective 3 May 2024 | §12.2 (5-year validity), §12.5 (payment does not equal registration status), §11.0 (fees) |
Article 4(1)(c) deserves a note of its own: evidence of payment of the prescribed fee is part of the registration requirements themselves, so fee discipline starts at application and continues through every renewal cycle.
3. Expert insights
Insight one: 5 years is the certificate validity period, not the process cycle time.
The 5 years in Article 4(7) refer to the validity period of the registration certificate; the process cycle has its own figures — §12.7 of R&R-GDL-008-02 and §11.7 of VBM-R&RA-GDL-001-01 give two official practical estimates of 120 working days and 240 working days respectively (see article 13 for details). Do not mix the two timelines: one determines how often you must renew the certificate, the other determines how long it takes to obtain it in the first place. Budgeting teams that use the renewal figure to plan market entry, or the review figure to plan renewals, end up with calendars that are wrong in both directions.
Insight two: Article 8(3) designs resumption as two actions — notice plus payment.
The structure of Article 8(3) is that the holder must notify NAFDAC and, where the certificate has expired, pay the renewal fee. The key phrase is where expired — a certificate suspended while still within its validity period follows the resumption procedure; a certificate that has already expired is, in substance, a renewal to be caught up on. The latter requires payment of the renewal fee and will very likely involve a fresh round of dossier review, because NAFDAC is no longer restoring an existing authorisation but effectively re-establishing one.
Insight three: paying fees does not equal obtaining registration status — the official texts say so plainly.
§11.5 / §12.5: payment of the prescribed fee to NAFDAC does not by itself confer registration status (does not confer registration status). The same logic applies to renewal: paying the renewal fee does not mean the certificate is automatically renewed; the official approval and issuance of the renewed certificate remain decisive. We stressed this point when discussing fees in article 10, and it is even more easily misread in the renewal scenario, where companies assume that a payment receipt is proof of a valid licence. It is not, and auditors, tender committees and customs officers will all ask for the certificate, not the receipt.
Insight four: one of the six grounds in Article 8(1) is a suspension requested by the holder itself.
Article 8(1)(f): the holder issues a written notice of intention to suspend. This is a relatively unusual design — a company may proactively apply to suspend its own registration certificate, commonly seen during market strategy adjustments, supply chain interruptions, or the transition period of a product upgrade. A voluntary suspension still requires the resumption procedure of Article 8(3); do not assume that a suspension you requested yourself can be lifted at will. The written notice and its acknowledgment are the documents that will later support the resumption.
Insight five: renewal does not start on the expiry date.
Article 6 requires post-registration changes to be notified or pre-approved, Article 12 requires continuous fulfilment of PMS and vigilance obligations, and Article 11 requires storage and distribution under the approved labelling conditions. If unresolved changes, open compliance directives or unsubmitted PMS reports exist at the time of renewal, the renewal will stall. Start renewal preparation no later than 12 months before expiry. The renewal dossier is, in effect, an audit of everything that happened during the five years of validity, and the companies that pass it cleanly are the ones that kept their compliance records current all along.
4. Practical recommendations
- Maintain a certificate register that works backwards from the 5-year validity, with internal milestones of starting 12 months before expiry and submitting 6 months before expiry.
- Run four self-checks before renewal: whether all changes have been notified or approved; whether all compliance directives are closed; whether PMS and vigilance reports were submitted on time; whether labelling matches the approved version.
- After a suspension, first determine whether the certificate has expired — if it has, prepare as a renewal and budget the renewal fee.
- For voluntary suspension (Article 8(1)(f)), issue and retain written notice to preserve the trail for later resumption.
- Never treat a payment receipt as evidence of registration status (§11.5 / §12.5).
- Handle renewal fee amounts as a practical estimate, deferring to the current NAFDAC tariff schedule and case-by-case responses.
5. Verification checklist
- □ The certificate validity period is recorded as 5 years and renewal milestones are set (Article 4(7), §11.2 / §12.2).
- □ The four pre-renewal self-checks on changes, compliance directives, PMS / vigilance and labelling consistency have been completed.
- □ If the certificate was ever suspended or cancelled, whether it has expired has been confirmed and the resumption or renewal path chosen accordingly (Article 8(3)).
- □ Written notice of any voluntary suspension has been issued and retained (Article 8(1)(f)).
- □ Internally it is understood that payment does not equal registration status (§11.5 / §12.5).
- □ Renewal fees have been confirmed with the authorities case by case on a practical estimate basis.
Regulatory information verified as of 29 October 2026. All citations have been checked against the official NAFDAC Regulations text (S.I. No. 42 of 2024, Articles 4(1)(c), 4(7), 8(1)–(3)) and the two guidelines (VBM-R&RA-GDL-001-01 §10.0, §11.2, §11.5; R&R-GDL-008-02 §11.0, §12.2, §12.5); the renewal fee amount is referred to in the official texts only as the NAFDAC Tariff section. The tariff schedule itself was not obtained in this round, so fees are treated as a practical estimate.
- Local resources in Nigeria: GRZAN can coordinate locally licensed importer and authorised representative resources, covering NAPAMS electronic submission, dossier screening permit coordination, import permits, sample delivery and laboratory analysis support.
- Service capabilities: classification determination, registration pathway selection, technical documentation (IMDRF ToC), CMFS and legalisation, GMP and foreign inspection readiness, advertisement permits, vigilance and PMS reporting, change management and renewal.
- Contact: hito.lin@grzan.cn; website www.grzan.cn; email info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us